(Q46747650)
Statements
1 reference
Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia (English)
1 reference
Wen-Lin Xu
1 reference
Hui-Ling Shen
1 reference
Zhong-Fang Ao
1 reference
Bao-An Chen
1 reference
Wei Xia
1 reference
Feng Gao
1 reference
Yong-Ning Zhang
1 reference
10 October 2005
1 reference
1 reference
30
1 reference
4
1 reference
407-413
1 reference